Search the hub
Showing results for tags 'Virus'.
Found 2,337 results
-
Content ArticleThis report from CIPD examines the latest evidence and the experiences of employees experiencing long COVID, and offers recommendations for organisations on how to effectively support those with long COVID to return to, and stay in, work.
-
Content ArticleThis is the second of two dynamic reviews of the evidence around people’s experience of the enduring symptoms following a Covid-19 infection. The National Institute for Health Research published their first review of the evidence in October 2020. At the time there was uncertainty about the extent to which there could be lasting effects, and most people assumed a linear progression of a severe acute infection with a long recovery tail. The first review on “Living with Covid-19” was informed by the experience of professionals and the NIHR worked closely with a group of people with lived experience. This review focuses on the published evidence. In addition, it reports findings from a short survey of people living with Covid-19. With over 3,000 responses it provides an insight into the key issues and challenges for people living with Covid-19.
-
Content ArticleThe COVID-19 pandemic has led to changes in health service utilisation patterns and a rapid rise in care being delivered remotely. However, there has been little published research examining patients’ experiences of accessing remote consultations since COVID-19. Such research is important as remote methods for delivering some care may be maintained in the future.
-
Content ArticleRichard Murray, Chief Executive of The King’s Fund, comments on the NHS elective recovery plan.
-
Content ArticleThe single worst stressor on healthcare workers is the gap between what their patients need and what they can deliver. The covid-19 pandemic is making this divide wider than ever, writes Esther Choo in this BMJ article.
-
Content ArticleThe Covid-19 vaccination programme has been one of the few almost unqualified successes of the UK’s response to the pandemic. System-working, joining up the NHS, local government and the voluntary sector was a hallmark of the vaccine roll-out. Local knowledge and delivery were crucial. Volunteers also played a vital role, not just in acting as stewards at vaccination sites, but also in terms of community outreach, for example with faith communities and others offering sites for vaccination which in turn built trust in the vaccine and in the NHS. The NHS has never used so much data so quickly and so powerfully, supporting the delivery of vaccine doses, recording any adverse reactions and, most importantly, allowing NHS staff to map who had the vaccine. This data in turn supported outreach work to support gaps in service provision and overcome vaccine hesitancy. These factors which helped make the roll out a success should be ‘bottled and re-used’ for other NHS services, from childhood immunisations to screening for cancer, diabetes, high blood pressure and other conditions, improving the service’s ability to reach the harder to reach Based on interviews with a wide range of people involved in the programme, this King's Fund report sets out what the roll-out in England has achieved as well as its trials and tribulations.
-
Content ArticleThis study in the BMJ Open examines the links between between adverse childhood events and trust in Covid-19 health information, attitudes towards and compliance with Covid-19 restrictions and vaccine hesitancy. The study found correlations between adverse childhood events and: low trust in NHS Covid-19 information feeling unfairly restricted by government supporting removal of social distancing and ending of mandatory face coverings breaking Covid-19 restrictions vaccine hesitancy. The authors concluded that as adverse childhood events are common across many populations, there is a need to understand how they impact trust in health advice and uptake of medical interventions. This could play a critical role in the continuing response to Covid-19 and approaches to controlling future pandemics. In addition, as individuals with adverse childhood events suffer greater health risks throughout life, better compliance with public health advice is another reason to invest in safe, secure childhoods for all children.
-
Content ArticleThe resilience of health systems and cooperation between Member States have become particularly important during the COVID-19 pandemic. On the occasion of the French Presidency of the European Union (FPEU) 2022, the European Observatory on Health Systems and Policies and the General Directorate for HealthCare Services of the French Ministry of Health have worked together to produce this special issue of Eurohealth to better understand how health systems have responded to the health crisis and to draw lessons for improving resilience of health systems. (Available in both English and French.)
-
EventThis conference focuses on recognising and responding to the deteriorating patient and ensuring best practice in the use of NEWS2. The conference will include National Developments including the recommendations on NEWS2 and Covid-19, and implementing the recommendations from the Healthcare Safety Investigation Branch Report Investigation into recognising and responding to critically unwell patients. The day will include practical case study based sessions on identifying patients at risk of deterioration, improving practice in patient observations, the role of human factors in responding to the deteriorating patient, improving escalation and understanding success factors in escalation, sepsis and Covid-19, involving patients and families in recognising deterioration, using clinical judgement, and improving the communication and use of NEWS2 in the community, including care homes, and at the interface of care. The Recording of NEWS2 score, escalation time and response time for unplanned critical care admissions is now an NHS CQUIN goal. For further information and to book your place visit https://www.healthcareconferencesuk.co.uk/conferences-masterclasses/deteriorating-patient-summit or email kate@hc-uk.org.uk. hub members receive a 20% discount. Email: info@pslhub.org Follow on Twitter @HCUK_Clare #DeterioratingPatient
-
EventThis Westminster conference will discuss the future for Long Covid research, services, and care. It will be an opportunity to assess Long Covid: the NHS plan for improving Long Covid services and how its ambitions for improving access to services, patient experience and outcomes for patients can be achieved. Further sessions examine priorities for research and improving understanding of Long Covid, looking at implementing the latest developments in research to improve services, and the long-term health implications of Long Covid. There will also be discussion on addressing concerns around inequalities, capacity and wait times for Long Covid services, as well as the primary care referral system, and utilisation of investment. Sessions in the agenda include: latest developments: trends - key issues - assessing the NHS plan for improving long COVID services. clinical research: taking forward the understanding of Long Covid - advancing clinical trials - utilising data - funding and investment. improving patient outcomes, prediction and prevention - accelerating the development of effective treatments - areas for focus, such as cardiology. examining the increased risk of long-term health conditions and impacts of reinfection for Long Covid patients. improving specialist Long Covid services: progress made so far and priorities for moving forward. options for increasing capacity - addressing inequalities in provision, access to services and information - applying latest developments from research. children’s Long Covid services: assessing delivery - implications for child development and attainment. primary care: tackling key challenges for diagnosis and referral. the workforce: priorities for education and training - support for long COVID patients in the workforce. Register
-
EventuntilChaired by Patient Safety Learning's Helen Hughes, and sponsored by BD, an expert panel will discuss what measures are needed to achieve transformational change in the way infection is detected, monitored, prevented, and managed across the NHS, healthcare systems and broader society. The session will touch on how industry, professional bodies and healthcare experts can work collaboratively to support the creation of a healthcare system which is resilient and mature in dealing with disease outbreak and pandemic preparedness, infection prevention, and rapid treatment of time-critical infection, ultimately delivering antimicrobial stewardship (AMS) and improved sepsis outcomes. What attendees will learn: Understand the current challenges and barriers to effective infection prevention. What the future of infection prevention and management looks like in a post-COVID-19 world. Collaboration between all stakeholders – industry, government and PAGs – will be critical in delivering a holistic solution and pathway to robust infection management. Register
-
EventThe COVID-19 pandemic has profoundly impacted nearly all countries’ health systems and diminished their capability to provide safe health care, specifically due to errors, harm and delays in diagnosis, treatment and care management. “Implications of the COVID-19 pandemic for patient safety: a rapid review” emphasises the high risk of avoidable harm to patients, health workers, and the general public, and exposes a range of safety gaps across all core components of health systems at all levels. The disruptive and transformative impacts of the pandemic have confirmed patient safety as a critical health system issue and a global public health concern. The objectives of the WHO event are : provide an overview of implications of the COVID-19 pandemic for patients, health workers, and the general public highlight importance of managing risks and addressing avoidable harm in a pandemic situation discuss implications of the pandemic for patient safety within broader context of preparedness, response and recovery lay the foundation for follow-up work around generating more robust evidence and supporting countries in their efforts to build resilient and safer health care systems. Register
-
Community PostTwo vaccines for COVID-19 have now been approved. Health organisations are doing their upmost to workout how best to store and administer the vaccines safely and avoiding errors. The Chartered Institute of Ergonomics and Human Factors (CIEHF) are preparing strategic guidance for health authorities and operational guidance for people setting up vaccine programmes applicable internationally. In a recent LinkedIn post, Chief Executive Noorzaman Rashid asks: "What are the Human Factors and Ergonomic issues that should be considered?" And asks you to share your ideas: https://www.linkedin.com/posts/noorzamanrashid_the-economist-on-twitter-activity-6750290388721926144-h8XV/ #ciehf #covid #patientsafety
- Posted
- 5 replies
-
- (and 2 more)
-
Community Post
Emergency approval for a covid vaccine - a patient safety concern?
Sam posted a topic in Coronavirus (COVID-19)
- (and 2 more)
The UK government is seeking views on proposed changes to the Human Medicine Regulations 2012 to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other diseases that become pandemic. Ministers say there will be no shortcut on safety or effectiveness, and that any vaccine will be approved for the UK only if it meets the highest standards. The deputy chief medical officer for England, Prof Jonathan Van-Tam, said: “If we develop effective vaccines, it’s important we make them available to patients as quickly as possible but only once strict safety standards have been met. The proposals consulted on today suggest ways to improve access and ensure as many people are protected from Covid-19 and flu as possible without sacrificing the absolute need to ensure that any vaccine used is both safe and effective.” What do you think? Are there patient safety concerns here? We'd love to hear your views. Comment below.- Posted
- 1 reply
-
- (and 2 more)
-
Community PostWhy do we need GP referrals to this service for assessment? Early patients untested cannot get access to GPs, not being believed, dismissed, told they are delusional. se have been sat for months unable to get referrals ...today someone got a referral and the NHS denied them that too. So we are getting no support. We are having a host of around 200 effects (Ive documented them), most of us are weeks 12 to 33 and having lung cognitive and heart problems. We needs mri and ct scans now and we cant be joining the back of already lengthy outpatient appointments. theresa huge backlog. When is someone going to help us? #longtailgoing viral @postcovidsynd Post Covid 19 Syndrome Support Group International (facebook). Sir Simon Stevens from NHS England doesn't have time to answer our letter, he said the Seacole Centre has been set up...but it only takes tested positive patietns and the phone numbers don't work. He told us to watch himself on the Andrew Marr show..which was about this app. As you can see we still cant get referrals here either as we need GP referrals adn we cant get them/..did no one raise this? I think they did...as I did with Senior Government Advisors. Nothing has been offered to untested patients. The medical community are very much aware that we were sent home so to deny we are sick and label it as anxiety is a scandal. Likewise, graded therapy (I note exercise is on here) is not recommended as we have heart problems and some of us have done it and had heart attacks...dangerous information to share with people suffering 200 symptoms thatt the medical community have not followed us on .... health-problems (1).pdf
-
Community Post
COVID-19 risk assessments for BAME staff
PatientSafetyLearning Team posted a topic in Coronavirus (COVID-19)
- (and 2 more)
This topic has been created to provide our members with a space to share COVID-19 risk assessments for BAME staff. You can share your risk assessment resources by commenting below and adding an attachment. We've kicked things off by sharing an example below. If you are not yet a member of the hub, you'll need to sign up here first - it's quick and easy to do. By collaborating and sharing learning, we hope to reduce risk. Risk ax form .doc- Posted
- 2 replies
-
- (and 2 more)
-
Community PostFollowing the recent Patient Safety Learning webinar, ‘Patient safety: Time for questions? Non Covid-19 care and treatment’, we’ve gained a deeper understanding of the key issues frontline staff and patients are facing and have heard many more great ideas around how to address these issues and improve staff and patient safety. Due to its success, and the clear need to spend more time addressing the issues raised and identifying further issues, we plan to hold more webinars. So that we can determine what issues need to be addressed urgently, can you spare a few minutes to tell us about the issue/s related to patient safety and staff safety you are most concerned about? Please add your comments below.
-
Content Article
UK Covid 19 Inquiry Hearings
Patient Safety Learning posted an article in Covid-19 Inquiry
All the public and preliminary hearings from the Covid 19 Inquiry can be found here. -
Content ArticleReport, together with formal minutes relating to the report.
-
Content ArticleThere are reports of increasing incidence of paediatric diabetes since the onset of the COVID-19 pandemic. This study by D'Souza et al. compares the incidence rates of paediatric diabetes during and before the COVID-19 pandemic. The study found that incidence rates of type 1 diabetes and diabetic ketoacidosis at diabetes onset in children and adolescents were higher after the start of the COVID-19 pandemic than before the pandemic. Increased resources and support may be needed for the growing number of children and adolescents with diabetes. Future studies are needed to assess whether this trend persists and may help elucidate possible underlying mechanisms to explain temporal changes.
-
Content ArticleProfessor Brian Edwards summarises this week's evidence in the Covid-UK inquiry.
-
Content ArticleIn February 2023, the government commissioned an independent review to offer recommendations on how to resolve key challenges in conducting commercial clinical trials in the UK and transform the UK commercial clinical trial environment. The review sets out 27 recommendations, including both priority actions to progress in 2023 and longer-term ambitions for UK commercial clinical trials. The review was conducted by Lord James O’Shaughnessy, Senior Partner at consultancy firm Newmarket Strategy, Board Member of Health Data Research UK (HDR UK) and former Health Minister, who was appointed as review Chair. During the review, Lord O’Shaughnessy consulted closely with industry and a wide range of stakeholders across the UK clinical trials sector. The government response welcomes all recommendations from the review, in principle, and makes 5 headline commitments backed by £121 million. An implementation update, setting out progress made against these commitments and a comprehensive response to the remaining recommendations, will be published in the autumn.
-
Content ArticleThis podcast series from Julie Taylor aims to raise awareness of Long Covid, provide a platform of support, education and the lived experience. Julie is a registered nurse in the UK and became unwell with Covid in May 2020 while working on the frontline, during the first wave of the pandemic. She now lives with Long Covid and POTS (postural orthostatic tachycardia syndrome). In this podcast series, Julie shares her journey and lived experience, the symptoms and how each impacts daily life, not only the physical issues but also the impact this has had mentally and emotionally.
-
Content ArticleThe 'Living with Long Covid' podcast series from Julie Taylor aims to raise awareness of Long Covid, and provide a platform of support, education and the lived experience.
-
News Article
England to offer Covid jab to five to 11-year-olds
Patient Safety Learning posted a news article in News
Children aged between five and 11 in England will be offered a low-dose Covid vaccine, the government says. Official scientific advice concludes the move would help protect the "very small" number of children who become seriously ill with Covid. Health Secretary Sajid Javid says the rollout will be "non-urgent", with an emphasis on parental choice. Northern Ireland also said on Wednesday it will be following Wales and Scotland in offering young children the vaccine. Children are at a much lower risk of becoming severely ill from a Covid infection, so the health benefits of vaccinating them are smaller than in other age-groups. Also, many will have some protection from already having caught the virus. So the scientists on the Joint Committee on Vaccination and Immunisation (JCVI), which advises governments across the UK, have been weighing up the evidence for immunising five to 11-year-olds. It concluded vaccination should go ahead to prevent a "very small number of children from serious illness and hospitalisation" in a future wave of Covid. Prof Wei Shen Lim, from the JCVI, said: "We're offering this to five to 11-year-olds now in order to future-proof their defences against a future wave of infection." He suggested parents consider getting their children vaccinated during school holidays to minimise disruption to their education from any flu-like side effects of the jab. Read full story Source: BBC News, 16 February 2022
